HIV infection and aging: mechanisms to explain the accelerated rate of progression in the older patient

[1]  I D Gardner,et al.  The effect of aging on susceptibility to infection. , 1980, Reviews of infectious diseases.

[2]  J. Fahey,et al.  Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. , 1984, Journal of immunology.

[3]  J. Fackler,et al.  Epstein-Barr virus infection in a child with acquired immunodeficiency syndrome. , 1985, American journal of diseases of children.

[4]  D. Stoll,et al.  Diminished interleukin 2 production and receptor generation characterize the acquired immunodeficiency syndrome. , 1985, Clinical immunology and immunopathology.

[5]  D. Longo,et al.  Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. , 1985, The American journal of medicine.

[6]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[7]  K. Sethi,et al.  Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome. , 1986, Immunology letters.

[8]  Prince He,et al.  Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders. , 1986 .

[9]  S. Gupta.  Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. , 1986, Clinical immunology and immunopathology.

[10]  J. Levy,et al.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.

[11]  W. P. Glezen,et al.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.

[12]  B. Truman,et al.  Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. , 1987, The New England journal of medicine.

[13]  J. Margolick,et al.  Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. , 1987, Journal of immunology.

[14]  H. Prince,et al.  Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders. , 1987, Clinical and experimental immunology.

[15]  J. Goedert,et al.  Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. , 1987, Annals of internal medicine.

[16]  H. Jaffe,et al.  Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. , 1988, JAMA.

[17]  S. Kleinman,et al.  Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. , 1988, Journal of immunology.

[18]  H. Prince,et al.  In vitro activation of T lymphocytes from HIV-seropositive blood donors. II. Decreased mitogen-induced expression of interleukin 2 receptor by both CD4 and CD8 cell subsets. , 1988, Clinical immunology and immunopathology.

[19]  R. Chaisson,et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.

[20]  R. Chaisson,et al.  Survival patterns of the first 500 patients with AIDS in San Francisco. , 1988, The Journal of infectious diseases.

[21]  R. Doll,et al.  Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom. , 1989, BMJ.

[22]  N. Jewell,et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. , 1989, Journal of acquired immune deficiency syndromes.

[23]  J. Goedert,et al.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.

[24]  L. Kingsley,et al.  Defective T cell colony formation and IL-2 receptor expression in HIV-infected homosexuals: relationship between functional abnormalities and CD4 cell numbers. , 1989, Journal of acquired immune deficiency syndromes.

[25]  J. V. van Dongen,et al.  Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids. , 1989, Virology.

[26]  G. Gaudernack,et al.  CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. , 1990, Journal of immunology.

[27]  B. Moss,et al.  CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Miedema,et al.  Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. , 1990, The Journal of clinical investigation.

[29]  T. Matthews,et al.  Human immunodeficiency virus‐1 disease progression in hemophiliacs , 1990, American journal of hematology.

[30]  J. Justement,et al.  Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Azen,et al.  Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. , 1990 .

[32]  J. Pocidalo,et al.  T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non‐progressors and progressors towards AIDS , 1990, Clinical and experimental immunology.

[33]  R. Doll,et al.  Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. , 1990, Statistics in medicine.

[34]  M. Baseler,et al.  Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. , 1990, Journal of immunology.

[35]  A. Blaxhult,et al.  The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. , 1990, AIDS.

[36]  B. Moss,et al.  Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells , 1990, Journal of virology.

[37]  G. Rutherford,et al.  Survival trends for patients with AIDS. , 1990, JAMA.

[38]  S. Shahabuddin.  Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets. , 1991, Journal of clinical & laboratory immunology.

[39]  D. Weiner,et al.  Human genes other than CD4 facilitate HIV-1 infection of murine cells. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[40]  J. Levy,et al.  Rapid CD8+ Cell Anti-HIV Activity Correlates with the Clinical State of the Infected Individual , 2003 .

[41]  R. Selik,et al.  Epidemiology of Acquired Immune Deficiency Syndrome in Persons Aged 50 Years or Older , 1991, Journal of acquired immune deficiency syndromes.

[42]  J Elford,et al.  More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. , 1991, Journal of acquired immune deficiency syndromes.

[43]  H. Prince,et al.  Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. , 1991, Journal of acquired immune deficiency syndromes.

[44]  R. Chaisson,et al.  Age-related changes in the immune function of HIV-1 seropositive adults , 1991 .

[45]  R. Weiss,et al.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus , 1991, Virology.

[46]  A. Capron,et al.  Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. , 1991, Immunology today.

[47]  J. Levy,et al.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism , 1991, Journal of virology.

[48]  W. Cumberland,et al.  Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. , 1992, Journal of acquired immune deficiency syndromes.

[49]  D S Stein,et al.  CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. , 1992, The Journal of infectious diseases.

[50]  I. Salit,et al.  HIV infection in patients over 55 years of age. , 1992, Journal of acquired immune deficiency syndromes.

[51]  N. Haigwood,et al.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.

[52]  R. Kaslow,et al.  The progression of untreated HIV-1 infection prior to AIDS. , 1992, American journal of public health.

[53]  M. Fletcher,et al.  Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. , 1992 .

[54]  P. Mason,et al.  Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection. , 1992, Clinical immunology and immunopathology.

[55]  P. Charneau,et al.  Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons , 1992, Journal of virology.

[56]  L. Adleman,et al.  T-cell homeostasis: implications in HIV infection . , 1993, Journal of acquired immune deficiency syndromes.

[57]  J. Margolick,et al.  Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[58]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[59]  Anthony S. Fauci,et al.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease , 1993, Nature.

[60]  P. Krijnen,et al.  Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.

[61]  J. Kaldor,et al.  Development of AIDS in people with transfusion-acquired HIV infection. , 1993, AIDS.

[62]  E. Vittinghoff,et al.  The characterization of non‐progressors: long‐term HIV‐1 infection with stable CD4+ T‐cell levels , 1993, AIDS.

[63]  A. Fauci,et al.  Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Powers.  Influenza A Virus‐Specific Cytotoxic T Lymphocyte Activity Declines with Advancing Age , 1993, Journal of The American Geriatrics Society.

[65]  C. Sabin,et al.  CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. , 1993, AIDS.

[66]  J. Chmiel,et al.  Tracking of markers and onset of disease among HIV-1 seroconverters. , 1993, Statistics in medicine.

[67]  J. Timpone,et al.  Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  C. Cambiaggi,et al.  Susceptibility of human-mouse T cell hybrids to HIV-productive infection. , 1993, AIDS research and human retroviruses.

[69]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[70]  Ashley T. Haase,et al.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.

[71]  S. Rowland-Jones,et al.  Cytotoxic t lymphocytes in hiv infection , 1993 .

[72]  J. Levy,et al.  An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. , 1993, Clinical immunology and immunopathology.

[73]  E. Thompson,et al.  Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals Correlation with local production of specific IgM and IgG antibodies , 1993, Journal of the Neurological Sciences.

[74]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[75]  M. Alizon,et al.  Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2 , 1993, Journal of virology.

[76]  R. Steinman,et al.  Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 , 1994, Cell.

[77]  T. Spira,et al.  Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults. , 1994, Clinical immunology and immunopathology.

[78]  I. Keet,et al.  Predictors of disease progression in HIV‐infected homosexual men with CD4+ cells <200 x 106/l but free of AIDS‐defining clinical disease , 1994, AIDS.

[79]  M. Morfini,et al.  Clinical Factors Associated with Progression to AIDS in the Italian Cohort of HIV-Positive Hemophiliacs , 1994, Thrombosis and Haemostasis.

[80]  M. de Carli,et al.  Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.

[81]  James J. Goedert,et al.  Effect of age at seroconversion on the natural AIDS incubation distribution , 1994, AIDS.

[82]  J. Montaner,et al.  Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV‐infected homosexual men , 1994, AIDS.

[83]  Richard A. Miller,et al.  Age-associated changes in human T cell phenotype and function , 1994, Aging.

[84]  D. Cooper,et al.  Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. , 1994, American journal of epidemiology.

[85]  C. Rouzioux,et al.  Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients , 1994 .

[86]  A. Fauci,et al.  Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.

[87]  G. Vanham,et al.  Selective increase of activation antigens HLA‐DR and CD38 on CD45RO+ T lymphocytes during HIV‐1 infection , 1994, Clinical and experimental immunology.

[88]  J. Goedert,et al.  Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. , 1995, American journal of epidemiology.

[89]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[90]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[91]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[92]  Paradox remains , 1995, Nature.

[93]  B. Premack,et al.  Activation of dual T cell signaling pathways by the chemokine RANTES. , 1995, Science.

[94]  D. Ho,et al.  A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. , 1995, The New England journal of medicine.

[95]  J. Levy,et al.  Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[96]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[97]  J. Mellors,et al.  Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.

[98]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[99]  W. Mccarthy,et al.  Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. , 1995, The Journal of infectious diseases.

[100]  M. Bukrinsky,et al.  Other approaches , 1995, Nature.

[101]  J. Margolick,et al.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.

[102]  C. Rinaldo,et al.  Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. , 1995, AIDS research and human retroviruses.

[103]  J. Margolick,et al.  Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[104]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.

[105]  J. Phair,et al.  Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL. , 1995, The Journal of infectious diseases.

[106]  K. Metzner,et al.  HIV suppression by interleukin-16 , 1995, Nature.

[107]  A. Fauci,et al.  New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.

[108]  A. Kelso.  Th1 and Th2 subsets: paradigms lost? , 1995, Immunology today.

[109]  D. Mosier.  CD4+ cell turnover , 1995, Nature.

[110]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[111]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[112]  L. M. Lehman,et al.  A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. , 1995, The New England journal of medicine.

[113]  C. Rinaldo,et al.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.

[114]  J. Chmiel,et al.  Survival from early, intermediate, and late stages of HIV infection. , 1996, JAMA.

[115]  M. Phelouzat,et al.  Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence , 1996, Mechanisms of Ageing and Development.

[116]  L. Adleman,et al.  Blind T-cell homeostasis in CD4-deficient mice. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[117]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[118]  R. Weiss,et al.  Hot fusion of HIV , 1996, Nature.

[119]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[120]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[121]  L. Montagnier,et al.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. , 1996, Journal of immunology.

[122]  Y. Chen,et al.  CD8+ T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1 alpha and MIP-1 beta. , 1996, AIDS.

[123]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[124]  C. Caruso,et al.  Cytokine production pathway in the elderly , 1996, Immunologic research.

[125]  L. Papagno,et al.  Chemokine production in HIV-seropositive long-term asymptomatic individuals. , 1996, AIDS.

[126]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[127]  D. Ho,et al.  Viral Counts Count in HIV Infection , 1996, Science.

[128]  K. Sperber,et al.  Altered cytokine production and accessory cell function after HIV-1 infection. , 1996, Journal of immunology.

[129]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[130]  J. Levy,et al.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.

[131]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[132]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[133]  M. Feinberg.  Changing the natural history of HIV disease , 1996, The Lancet.

[134]  J. Goedert,et al.  Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. , 1996, JAMA.

[135]  C. Payá,et al.  Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes , 1996, Journal of virology.

[136]  P. Volberding.  Age as a predictor of progression in HIV infection , 1996, The Lancet.

[137]  D. Cooper,et al.  Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. , 1996, The Journal of infectious diseases.

[138]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[139]  J. Levy,et al.  Plasma Viral Load, CD4+ Cell Counts, and HIV-1 Production by Cells , 1996, Science.

[140]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[141]  A. Sönnerborg,et al.  Site‐directed serology of HIV‐1 subtype B infection: relation between virus specific antibody levels and disease progression , 1996, Clinical and experimental immunology.

[142]  D. R. Kuritzkes,et al.  HIV viral load markers in clinical practice , 1996, Nature Medicine.

[143]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[144]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[145]  B. Walker,et al.  Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. , 1996, AIDS research and human retroviruses.

[146]  T. Jussila,et al.  RANTES, MIP and interleukin-16 in HIV infection. , 1996, AIDS.

[147]  C. Rizza,et al.  Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population , 1996, The Lancet.

[148]  J. Metcalf,et al.  Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.

[149]  C. Walker,et al.  RANTES, MIP-1α and MIP-1β are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones , 1996 .

[150]  M. Clerici,et al.  CD8+ lymphocyte phenotype and cytokine production in long‐term non‐progressor and in progressor patients with HIV‐1 infection , 1996, Clinical and experimental immunology.

[151]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[152]  C. Engwerda,et al.  Cytokine production by T lymphocytes from young and aged mice. , 1996, Journal of immunology.

[153]  U. Tirelli,et al.  Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. , 1996, AIDS.

[154]  P. Simmonds,et al.  Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1 , 1996, The Lancet.

[155]  E. Tacconelli,et al.  Age as a prognostic factor in AIDS , 1996, The Lancet.

[156]  C. Sabin,et al.  Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. , 1996, AIDS.

[157]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[158]  W. Cruikshank,et al.  IL-16 represses HIV-1 promoter activity. , 1997, Journal of immunology.